902 related articles for article (PubMed ID: 22278151)
1. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
[TBL] [Abstract][Full Text] [Related]
2. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
3. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
[TBL] [Abstract][Full Text] [Related]
4. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
[TBL] [Abstract][Full Text] [Related]
5. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
6. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
[TBL] [Abstract][Full Text] [Related]
7. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
[TBL] [Abstract][Full Text] [Related]
8. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
[TBL] [Abstract][Full Text] [Related]
9. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.
Pocnet C; Antonietti JP; Donati A; Popp J; Rossier J; von Gunten A
Int Psychogeriatr; 2015 Aug; 27(8):1379-89. PubMed ID: 25592615
[TBL] [Abstract][Full Text] [Related]
11. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
12. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
13. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
Park JH; Park H; Sohn SW; Kim S; Park KW
Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
[TBL] [Abstract][Full Text] [Related]
14. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
Nogueira J; Freitas S; Duro D; Almeida J; Santana I
Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
[TBL] [Abstract][Full Text] [Related]
15. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM
Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment.
García-Herranz S; Díaz-Mardomingo MC; Peraita H
J Neuropsychol; 2016 Sep; 10(2):239-55. PubMed ID: 25809316
[TBL] [Abstract][Full Text] [Related]
17. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
[TBL] [Abstract][Full Text] [Related]
18. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
[TBL] [Abstract][Full Text] [Related]
19. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
20. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
Papp E; Pákáski M; Drótos G; Kálmán J
Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]